Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill
Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.
(Click On Video to Unmute)
Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.
Leave a Reply